Why 2026 Is a Pivotal Year for Supplement Enforcement
FDA enforcement letters targeting dietary supplement companies have been steadily increasing over the past three years. In 2026, the pattern has sharpened: the agency is focusing specifically on online marketing content — websites, product pages, social media, and email campaigns — rather than just product labels.
This shift matters because many brands treat their website copy with far less scrutiny than their label text. A product label gets reviewed by regulatory affairs. The blog post written by the marketing team often does not.
FDA can cite your website, Amazon listing, social media posts, and even customer testimonials as evidence of a product's intended use — turning a supplement into an unapproved drug in the eyes of the law.
Below are the seven triggers that appear most frequently in recent warning letters. For each one, we show the problematic language pattern and offer a safer alternative.
Trigger #1: Explicit Disease Claims
Any claim that a product prevents, treats, cures, or mitigates a specific named disease is an explicit disease claim requiring FDA drug approval. This is the clearest and most common warning letter trigger.
Named diseases include not just major conditions like cancer or diabetes, but also common ones like arthritis, depression, ADHD, and seasonal allergies. If a condition has an established ICD code, it is almost certainly a disease in FDA's view.
Trigger #2: "Cures" and "Treats" Language
The words "cures," "treats," "heals," "eliminates," and "reverses" almost always signal a drug claim when applied to a health condition. Even if the condition named seems mild, these action verbs move language into drug claim territory.
Run a simple test on your copy: replace your health claim verb with "treats" and ask whether it now sounds like a drug claim. If yes, your original verb likely has the same problem in FDA's eyes.
Trigger #3: Implied Disease References
You don't have to name a disease explicitly to trigger enforcement. Describing the symptoms of a disease, using disease imagery, or targeting people "who have" a condition implies disease treatment just as clearly as naming the condition outright.
This is one of the trickiest areas — and one of the places where Clara AI's analysis tends to catch things that human reviewers miss. The implied claim is often buried in product storytelling or testimonial framing.
Trigger #4: Unsubstantiated "Clinically Proven" Claims
The FTC — often acting in coordination with FDA — requires that "clinically proven" claims be backed by well-controlled clinical evidence on the actual finished product. A handful of ingredient-level studies rarely meets this bar. The claim misleads consumers about the strength of evidence behind the product.
Trigger #5: Missing or Improperly Placed Disclaimers
Even perfectly worded structure/function claims require the DSHEA disclaimer on the same page or in close proximity. Many brands include it on the label but omit it from their website product pages, blog posts, and social media. The disclaimer must appear in the same visual field as the claim when presented digitally.
On a webpage, the disclaimer should be near the claim — not only in the footer. If someone reads your product claim without scrolling down to the footer, and there is no disclaimer near the claim, that may be viewed as non-compliant.
Trigger #6: Testimonials That Make Disease Claims
Customer testimonials are treated as claims about your product's intended use. If a testimonial makes a disease claim — even if the customer wrote it independently — and you display it on your website or marketing materials, FDA can cite that testimonial as evidence the product is being marketed as a drug.
Trigger #7: Structure/Function Claims Without Substantiation
Structure/function claims are legal — but they must be truthful, not misleading, and substantiated by competent and reliable scientific evidence. Many brands make these claims without maintaining a substantiation file. If FDA asks, you need to be able to produce the evidence. The absence of documentation is itself a compliance risk.
What To Do Right Now
If you haven't done a full compliance review of your website and marketing content recently, these are your immediate action steps:
- Audit your product pages for the seven trigger patterns above — particularly testimonial sections and blog content written by marketing rather than regulatory staff.
- Verify disclaimers appear near structure/function claims on every page, not just in the global footer.
- Review testimonials currently published across your website, Amazon listings, and social media for disease language.
- Build substantiation files for any health claims you plan to keep.
- Run a scan with ScanCompliant — our platform reviews your website, social accounts, and documents against the built-in claim-risk library and flags the specific language that matches these enforcement patterns.
ScanCompliant reviews your website, Amazon listings, social media, and documents in minutes — flagging language that matches FDA and FTC enforcement patterns and suggesting lower-risk alternatives through Clara AI. Start a free 5-day trial →